Article
Raloxifene increases prefrontal activity during emotional inhibition in schizophrenia based on estrogen receptor genotype.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Dec 2016
Kindler Jochen, Weickert Cynthia Shannon, Schofield Peter R, Lenroot Rhoshel, Weickert Thomas W
Abstract excerpt
People with schizophrenia show decreased prefrontal cortex (PFC) activity during emotional response inhibition, a cognitive process sensitive to hormonal influences. Raloxifene, a selective estrogen receptor modulator, binds estrogen receptor alpha (ESR-α), improves memory, attention and normalizes cortical and hippocampal activity during learning and emotional face recognition in schizophrenia. Here, we tested...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
